Featured Research

from universities, journals, and other organizations

Nobody likes a 'fat-talker,' study shows

Date:
May 9, 2013
Source:
University of Notre Dame
Summary:
Women who engage in "fat talk" -- the self-disparaging remarks girls and women make in relation to eating, exercise or their bodies -- are less liked by their peers, a new study from the University of Notre Dame finds.

Women who engage in "fat talk" -- the self-disparaging remarks girls and women make in relation to eating, exercise or their bodies -- are less liked by their peers, a new study from the University of Notre Dame finds.

Led by Alexandra Corning, research associate professor of psychology and director of Notre Dame's Body Image and Eating Disorder Lab, the study was presented recently at the Midwestern Psychological Association annual conference.

In the study, college-age women were presented with a series of photos of either noticeably thin or noticeably overweight women engaging in either "fat talk" or positive body talk; they were then asked to rate the women on various dimensions, including how likeable they were.

The women in the photos were rated significantly less likeable when they made "fat talk" statements about their bodies, whether or not they were overweight. The women rated most likeable were the overweight women who made positive statements about their bodies.

"Though it has become a regular part of everyday conversation, 'fat talk' is far from innocuous," according to Corning.

"It is strongly associated with, and can even cause, body dissatisfaction, which is a known risk factor for the development of eating disorders."

Although fat talk has been thought of by psychologists as a way women may attempt to initiate and strengthen their social bonds, Corning's research finds that fat-talkers are liked less than women who make positive statements about their bodies.

"These findings are important because they raise awareness about how women actually are being perceived when they engage in this self-abasing kind of talk," Corning says.

"This knowledge can be used to help national efforts to reduce 'fat talking' on college campuses."


Story Source:

The above story is based on materials provided by University of Notre Dame. The original article was written by Susan Guibert. Note: Materials may be edited for content and length.


Cite This Page:

University of Notre Dame. "Nobody likes a 'fat-talker,' study shows." ScienceDaily. ScienceDaily, 9 May 2013. <www.sciencedaily.com/releases/2013/05/130509154547.htm>.
University of Notre Dame. (2013, May 9). Nobody likes a 'fat-talker,' study shows. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/05/130509154547.htm
University of Notre Dame. "Nobody likes a 'fat-talker,' study shows." ScienceDaily. www.sciencedaily.com/releases/2013/05/130509154547.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins